Tag: Metastatic cancer

Over 280,000 new cases of prostate cancer are estimated in the US annually, with hormone therapy being a cornerstone of treatment for advanced stages. The medication known as **Casodex** is one such hormonal therapy, but what is **Casodex** used for and how does it function within a treatment plan?

Originally approved by the FDA in 1995 for treating prostate cancer, bicalutamide is a hormonal therapy medication that blocks the effects of male hormones. This non-steroidal antiandrogen is a key component of cancer treatment strategies to stop the growth and spread of hormone-sensitive cancer cells. This article explores the primary uses, mechanism, and essential details regarding **what is bicalutamide used for**.

Tebentafusp was the first-in-class T-cell receptor therapeutic to be approved by the FDA, representing a significant breakthrough in cancer treatment. This innovative immunotherapy, also known by its brand name Kimmtrak, is a targeted therapy for adults with unresectable or metastatic uveal melanoma.